Pathologic complete response after neoadjuvant paclitaxel and carboplatin chemotherapy for stage II-III breast cancer: A community cancer center experience.

被引：0
|
作者：
Belur, Anuradha
Raajasekar, Arun Kumar Arumugam
Burdette-Radoux, Susan
机构：
[1] Maimonides Canc Ctr, Brooklyn, NY USA
[2] Maimonides Hosp, Brooklyn, NY 11219 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 28期
关键词：
D O I：
10.1200/jco.2015.33.28_suppl.43
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
43
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer
    Yildirim, Emine
    Bektas, Sibel
    Yetis, Firat
    Yildiz, Eren Ozan
    Ozdemir, Muhammed
    Komut, Neslihan
    Calik, Mustafa
    Er, Ahmet Muzaffer
    ANNALI ITALIANI DI CHIRURGIA, 2023, 94 (04) : 336 - 345
  • [22] MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
    Weber, Joseph J.
    Jochelson, Maxine S.
    Eaton, Anne
    Zabor, Emily C.
    Barrio, Andrea V.
    Gemignani, Mary L.
    Pilewskie, Melissa
    Van Zee, Kimberly J.
    Morrow, Monica
    El-Tamer, Mahmoud
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (06) : 740 - 746
  • [23] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    M Tanioka
    C Shimizu
    K Yonemori
    K Yoshimura
    K Tamura
    T Kouno
    M Ando
    N Katsumata
    H Tsuda
    T Kinoshita
    Y Fujiwara
    British Journal of Cancer, 2010, 103 : 297 - 302
  • [24] Predictors of Pathologic Complete Response in Axillary Nodes After Neoadjuvant Chemotherapy for Breast Cancer
    Ahn, Soojin
    Romeiser, Jamie
    O'Hea, Brian
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : 24 - 25
  • [25] Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
    Tanioka, M.
    Shimizu, C.
    Yonemori, K.
    Yoshimura, K.
    Tamura, K.
    Kouno, T.
    Ando, M.
    Katsumata, N.
    Tsuda, H.
    Kinoshita, T.
    Fujiwara, Y.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 297 - 302
  • [26] MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer
    Sener, Stephen F.
    Sargent, Rachel E.
    Lee, Connie
    Manchandia, Tejas
    Le-Tran, Vivian
    Olimpiadi, Yuliya
    Zaremba, Nicole
    Alabd, Andrew
    Nelson, Maria
    Lang, Julie E.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) : 903 - 910
  • [27] Pathologic complete response after neoadjuvant chemotherapy as a real surrogate endpoint of outcome for all breast cancer subtypes? Results of a single institution experience.
    Fuso, Paola
    Di Salvatore, Mariantonietta
    Rossi, Ernesto
    Orlandi, Armando
    Pozzo, Carmelo
    Cassano, Alessandra
    Astone, Antonio
    Barone, Carlo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II-III triple negative breast cancer: a retrospective analysis
    Wang, Huibo
    Zhang, Nana
    Sun, Qi
    Zhao, Ziqi
    Pang, Hui
    Huang, Xiatian
    Zhang, Ruifeng
    Kang, Wenli
    Shan, Ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [29] Bisphosphonates and Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Gregor, M. Chavez-Mac
    Brown, E. N.
    Lei, X.
    Hsu, L.
    Meric-Bernstam, F.
    Litton, J.
    Mittendorf, E. A.
    Valero, V.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    CANCER RESEARCH, 2010, 70
  • [30] Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian Bill
    Krishnamurti, Uma
    Bhattarai, Shristi
    Ktimov, Sergey
    Reid, Michelle D.
    O'Regan, Ruth
    Aneja, Ritu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (06) : 871 - 878
12345